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MaOBJECTIVES This study sought to assess the effect of coronary artery calcium (CAC) on coronary heart disease
(CHD) risk prediction in a younger population.
BACKGROUND CAC measured by computed tomography improves CHD risk classiﬁcation in older adults, but the
effectiveness of CAC in younger populations has not been fully assessed.
METHODS In the DHS (Dallas Heart Study), a multiethnic probability-based population sample, traditional
CHD risk factors and CAC were measured in participants without baseline cardiovascular disease or diabetes.
Incident CHD—deﬁned as CHD death, myocardial infarction, or coronary revascularization—was assessed
over a median follow-up of 9.2 years. Predicted CHD risk was assessed with a Weibull model inclusive of
traditional risk factors before and after the addition of CAC as ln(CAC þ 1). Participants were divided into
3 10-year risk categories, <6%, 6% to <20%, and $20%, and the net reclassiﬁcation improvement (NRI)
was calculated. We also performed a random-effects meta-analysis of NRI from previous studies inclusive
of older individuals.
RESULTS The analysis comprised 2,084 participants; mean age was 44.4  9.0 years. CAC was independently
associated with incident CHD (hazard ratio per SD: 1.90, 95% conﬁdence interval [CI] 1.51 to 2.38; p < 0.001).
The addition of CAC to the traditional risk factor model resulted in signiﬁcant improvement in the C-statistic
(delta ¼ 0.03; p ¼ 0.003). Among participants with CHD events, the addition of CAC resulted in net correct
upward reclassiﬁcation of 21%, and among those without CHD, a net correct downward reclassiﬁcation of 0.5%
(NRI: 0.216, p ¼ 0.012). Results remained signiﬁcant when the outcome was restricted to CHD death and myocardial
infarction and when individuals with diabetes were included. The NRI observed in this study was similar to the
pooled estimate from previous studies (0.200, 95% CI: 0.140 to 0.258) and the addition of our study to the
meta-analysis did not result in signiﬁcant heterogeneity (I2 ¼ 0%).
CONCLUSIONS CAC scoring also improves CHD risk classiﬁcation in younger adults. (J Am Coll Cardiol Img
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ABBR EV I A T I ON S
AND ACRONYMS
CAC = coronary artery calcium
CHD = coronary heart disease
CI = conﬁdence interval
HR = hazard ratio
MI = myocardial infarction
NRI = net reclassiﬁcation
improvement
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1286C oronary artery calcium (CAC)measured by computed tomographyhas emerged as a powerful predictor
of coronary heart disease (CHD) (1). Com-
pared with most other novel risk markers,
CAC has a greater impact on clinical metrics
of discrimination (i.e., C-statistics) and risk
classiﬁcation (i.e., net reclassiﬁcation im-
provement [NRI]) (2,3). In the most recent
cardiovascular risk assessment guidelines,CAC scanning received a Class IIb recommendation
(i.e., may be considered) for individuals ages 40
through 79 years in whom a risk-based treatment de-
cision is uncertain (4).SEE PAGE 1294Three population-based studies have assessed the
effects of CAC on CHD risk classiﬁcation, with each
study showing signiﬁcant improvement in C-statistics
and NRI when CAC was added to a traditional CHD
risk factor model (5–7). Because the mean age in those
cohorts ranged from 59 to 70 years, the effect of CAC
on risk reclassiﬁcation at the lower end of the age
group targeted in recent guidelines has not been fully
assessed.
We sought to determine the effects of CAC on CHD
risk prediction in a young, multiethnic, probability-
based population cohort and to compare our ﬁnd-
ings with data from older cohorts.
METHODS
STUDY SAMPLE. The DHS (Dallas Heart Study) is a
multiethnic, probability-based population cohort of
Dallas County adults, with deliberate oversampling of
African Americans. Detailed methods of DHS have
been described previously (8). All participants pro-
vided written informed consent, and the study
protocol was approved by the Institutional Review
Board of the University of Texas Southwestern Medi-
cal Center. Brieﬂy, between 2000 and 2002, 2,969
participants, ages 30 to 65 years, completed a detailed
in-home survey, laboratory testing, and multiple im-
aging studies. Of these 2,969 individuals, 226 did not
have an interpretable CAC scan; 74 reported previous
cardiovascular disease deﬁned as myocardial infarc-
tion (MI), stroke, or coronary revascularization; 6 had
end-stage renal disease; 88 had missing data on
traditional risk factor(s); and 191 had incomplete
follow-up for nonfatal events (Online Figure 1).
Because participants with diabetes (n ¼ 300) are
thought to have high cardiovascular risk, they were
not included in the primary analysis (9,10). The ﬁnal
study population comprised 2,084 subjects free ofdiabetes and cardiovascular disease who were fol-
lowed for fatal and nonfatal CHD events.
DEFINITIONS AND MEASUREMENTS. Race/ethnicity,
history of cardiovascular diseases, individual medi-
cation usage, and smoking status were self-reported.
Blood pressure, plasma glucose, and lipids were
measured using standard methods (8). Diabetes was
deﬁned as fasting glucose $126 mg/dl, or nonfasting
glucose $200 mg/dl, or reported diagnosis of diabetes
coupled with the use of glucose-lowering medication.
The study deﬁnitions of hypertension, metabolic
syndrome, and family history of premature CHD used
in the DHS have been previously published (11).
Electron-beam computed tomography measure-
ments of CAC were performed in duplicate 1 to 2 min
apart on an Imatron 150 XP scanner (Imatron Inc., San
Bruno, California). Sufﬁcient 3-mm slices were acquired
(n ¼w40) to span the heart during a single inspiratory
breath-hold (12). The 2 CAC scores were determined us-
ing the Agatston method and then averaged.
CLINICAL OUTCOMES. DHS participants were pro-
spectively followed for fatal and nonfatal cardiovas-
cular outcomes, and events were ascertained through
December 31, 2010 (13). Fatal events were tracked using
the National Death Index (14). Participants were con-
tacted annually and assessed for interval nonfatal
cardiovascular events. In addition, participants were
tracked for hospital admissions using the Dallas Fort
Worth Hospital Council Data Initiative database
(DFWHC ERF Information Quality Services Center Re-
gional Data [2000 to 2011]; Dallas-Fort Worth Hospital
Council Education and Research Foundation, Infor-
mation and Quality Services Center, Irving, Texas).
This includes hospital admission data for 70 of 72
hospitals in the Dallas Fort Worth metroplex. Using
these data sources,>90%of participantswere followed
for nonfatal events. Primary recordswere requested for
all suspected cardiovascular events, and these events
were separately adjudicated by 2 cardiologists blinded
to CAC assessment and all study variables (13).
The outcome for the primary analysis was deﬁned
as the time–to–ﬁrst event of the composite of CHD-
related death, nonfatal MI, or percutaneous or surgi-
cal coronary revascularization. All revascularization
events (coronary artery bypass graft surgery and
percutaneous revascularization) occurring within the
ﬁrst 3 months following CAC scanning were excluded
from the analyses to minimize the possibility that the
CAC test result inﬂuenced the revascularization event.
Secondary analyses were performed for the composite
outcome of hard CHD (CHD-related death and MI).
STATISTICAL ANALYSIS. Baseline demographic and
clinical variables were compared between individuals
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1287#50 and >50 years of age using the chi-square test
for categorical variables and Wilcoxon-rank sum for
continuous variables. Kaplan-Meier cumulative-event
curves were constructed for each CAC strata (i.e., 0,
>0 to 10, >10 to 100, and >100 Agatston units) and
unadjusted CHD events rates were compared using
log-rank statistics. Risk categories were deﬁned on the
basis of a baseline Weibull model that included age,
race, sex, systolic blood pressure, total and high den-
sity lipoprotein cholesterol, smoking status, blood
pressure medication, and statin use. As in previous
studies (5–7), categories were deﬁned as 10-year
risk <6%, 6% to <20%, and $20%. Because the mean
follow-up for the DHS was marginally shorter than 10
years (9.2 years), the Weibull proportional hazards
model was used to allow the computation of individual
10-year risk (15). In sensitivity analyses that included
participants with prevalent diabetes at baseline, dia-
betes was added as a covariate. CAC was added to the
baseline model as ln(CAC þ 1). Sensitivity analyses
were also performed using CAC as an ordinal variable
(0, 1 to 10, 11 to 100, 101 to 400, and >400). The pro-
portional hazards assumption was tested using
Schoenfeld residuals, and hazard ratios are reported
per SD and by CAC strata with CAC ¼ 0 as the reference
group. Cox models were used to generate adjusted
survival estimates for the primary endpoint according
to CAC strata. The same covariates included in the
Weibull models were used in the Cox models. Harrell
C-statistic was determined for the baseline model with
and without CAC and the difference between the 2 was
tested by bootstrapping (16). Sampling with replace-
ment was performed in 1,000 bootstrap samples. The
size of each sample was the same as the ﬁnal popula-
tion and signiﬁcance was assessed via a Student t test
with n – 2 degrees of freedom on these 1,000 samples.
Cross-tabulation of risk categories for the models with
and without CAC was performed for participants with
and without CHD events and the NRI was calculated
as described by Pencina et al. (17). Comprehensive age-
stratiﬁed analyses were performed among individuals
#50 and >50 years of age including Kaplan-Meier
cumulative-event curves as well as separate Weibull
and Cox models constructed for each age group. The
interaction between age and CACwas tested by adding
a multiplicative variable to the fully adjusted Weibull
model. The same approach was used to test the inter-
action between CAC and race and CAC and sex.
Statistical analyses were performed using the SAS
software package version 9.2 (SAS Institute, Inc., Cary,
North Carolina).
REVIEW AND META-ANALYSIS. We conducted a
PubMed and Cochrane Collaboration database search
through December 2014 for studies assessing additionof CAC to a model composed of traditional CHD risk
factors and reporting NRI. The following search terms
were used and no restrictions were applied: “net
reclassiﬁcation improvement,” “net reclassiﬁcation
index,” “coronary artery calcium,” “coronary artery
calciﬁcation,” “coronary calcium,” and “coronary
calciﬁcation.” When multiple studies from the same
cohort were available, only the study reporting on the
more inclusive population was included (e.g., overall
population vs. population at intermediate risk). The
NRI was extracted from each study and SE were
calculated using the method described by Pencina
et al. (17). The summary NRI was computed using a
random-effects DerSimonian-Laird model, and het-
erogeneity between studies was tested with the
I2 statistics. DHS NRI was then compared with
the summary NRI from previous studies using the
z-score. Statistical analyses were performed using the
OpenMeta[Analyst] software package (Tufts Medical
Center, Boston, Massachusetts).
RESULTS
CORONARY ARTERY CALCIUM IN THE DALLAS
HEART STUDY. The mean age of the study population
was 44.4  9.0 years, 56.2% were women, and 45.9%
were African American (Table 1). Most participants
had CAC scores under 10 (82.9%) and were classiﬁed
as low CHD risk (<6% 10-year risk) on the basis of
the Framingham Risk Score (81.6%). Participants >50
years of age had a higher burden of traditional risk
factors and higher CAC scores (Table 1).
A total of 57 ﬁrst CHD events occurred over a
mean follow-up of 9.2  1.3 years (7 CHD deaths, 30
nonfatal MI, 8 coronary artery bypass graft surgeries,
and 12 percutaneous coronary revascularizations).
Online Figure 2 shows Kaplan-Meier estimates for the
primary composite CHD outcome stratiﬁed by CAC
strata. Increasing CAC score categories were crudely
associated with higher CHD event rates in the
overall population and in each age strata (log-rank
p < 0.001). Unadjusted hazard ratio (HR) for the
primary outcome with increasing CAC categories
considering CAC ¼ 0 as the reference were as follow:
0 < CAC #10: 1.75 (95% conﬁdence interval [CI]: 0.67
to 4.52; p ¼ 0.252); 10 < CAC #100: 11.55 (95% CI: 5.02
to 26.56; p < 0.01); and CAC >100: 22.09 (95% CI:
9.83 to 49.63; p < 0.001). Each categorical CAC stra-
tum over 10 Agatston units identiﬁed increasing risk
for the primary composite of all CHD events, as well
as for the composite of hard CHD events (excluding
coronary revascularization) (Online Figure 3).
After multivariable adjustment, CAC remained
independently associated with incident CHD (HR per
TABLE 1 Baseline Characteristics of the Study Population
Analysis Cohort
(n ¼ 2,084)
Age #50 yrs
(n ¼ 1,520)
Age >50 yrs
(n ¼ 564) p Value*
Age, yrs 44.4  9.0 40.0  5.8 56.4  4.0 <0.001
Women 56.2 54.6 60.3 0.019
Race/ethnicity
Black 45.9 44.9 48.9 0.103
White 35.7 33.2 41.8 <0.001
Hispanic 16.3 19.3 8.5 <0.001
Other 2.1 2.6 0.7 0.007
Current smoker 26.8 28.4 22.5 0.007
Systolic blood pressure, mm Hg 123 (114–133) 121 (112–130) 130 (119–142) <0.001
Family history of premature MI† 9.4 9.8 8.3 0.299
Total cholesterol, mg/dl 180 (157–205) 176 (153–200) 188 (167–215) <0.001
LDL-C, mg/dl 107 (84–129) 105 (83–127) 112 (88–136) <0.001
HDL-C, mg/dl 48 (40–58) 47 (40–57) 50 (42–62) <0.001
Triglycerides, mg/dl 95 (67–141) 90 (65–136) 107 (73–151) <0.001
Statins 4.7 2.0 11.9 <0.001
Aspirin 7.3 4.8 14.0 <0.001
Hypertension medications 16.2 10.1 32.5 <0.001
BMI, kg/m2 29 (25–33) 29 (25–33) 29 (26–34) 0.249
Creatinine, mg/dl 0.9 (0.7–1.0) 0.8 (0.7–1.0) 0.9 (0.8–1.0) 0.060
Metabolic syndrome 28.2 24.7 37.8 <0.001
FRS
<6% 81.6 89.1 61.2 <0.001
6% # FRS #20% 15.8 9.9 31.8 <0.001
>20% 2.6 1.0 7.1 <0.001
CAC score 0.5 (0.0–3.5) 0 (0.0–1.6) 3.6 (0.0–48.5) <0.001
0 49.9 57.7 28.9 <0.001
0 < CAC #10 33.0 33.3 32.3 <0.001
10 < CAC #100 10.3 6.3 20.9 <0.001
100 < CAC #400 5.1 2.3 12.8 <0.001
>400 1.7 0.5 5.1 <0.001
Values are mean  SD, %, or median (interquartile range). *The p values compare each characteristic between the 2 age strata. †Family history of premature MI was deﬁned as
MI occurring before the age of 50 years in a ﬁrst-degree male relative or before the age of 55 years in a female ﬁrst-degree relative.
BMI ¼ body mass index; CAC ¼ coronary artery calcium; FRS ¼ Framingham Risk Score; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; MI ¼ myocardial infarction.
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1288SD: 1.90, 95% CI: 1.51 to 2.38; p < 0.001). Figure 1
shows adjusted survival estimates for the primary
endpoint according to CAC strata from separate Cox
models for the overall population, individuals #50
years, and individuals >50 years. A graded associa-
tion between CAC strata and CHD event rates was
observed (p < 0.001) (Table 2).
The C-statistic for the baseline traditional risk
factor model was 0.86 (95% CI: 0.83 to 0.91). The
addition of CAC signiﬁcantly improved discrimina-
tion (C-statistic: 0.89, 95% CI: 0.86 to 0.93; p ¼ 0.003)
with the same pattern of results observed for the
outcome of hard CHD (change in C-statistic: 0.03;
p ¼ 0.012).
The cross-tabulation of predicted 10-year risk for
the baseline model and after the addition of CAC is
shown in Table 3. Among participants with CHD
events, CAC resulted in the net correct upward
reclassiﬁcation of 21.1% of individuals and, amongparticipants without CHD events, the net correct
downward reclassiﬁcation was 0.5% resulting in a NRI
of 0.216 (p ¼ 0.012) (Table 3). Restricting the outcome
to hard CHD events, the addition of CAC to the
baseline model resulted in the net correct reclassiﬁ-
cation of 32.4% of events with a NRI of 0.313 (p ¼
0.014). Including participants with diabetes, 80 ﬁrst
CHD events occurred and the addition of CAC to the
baseline model resulted in the net correct reclassiﬁ-
cation of 12.5% of events with a NRI of 0.135 (p ¼
0.043). In further sensitivity analyses, using CAC as
an ordinal variable (0, 1 to 10, 11 to 100, 101 to 400,
and >400) instead of a continuous variable, both the
change in C-statistic (0.02, p ¼ 0.016) and NRI (0.192,
p ¼ 0.023) remained signiﬁcant.
In the fully adjusted models, CAC was indepen-
dently associated with incident CHD among
participants #50 and >50 years of age (HR per SD:
1.56, 95% CI: 1.20 to 2.03; p < 0.001, and HR per SD:
FIGURE 1 Adjusted Survival Estimates for the Primary Endpoint According to CAC Strata
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(A) Overall population, the lines for the CAC score ¼ 0 and 0 < CAC #10 are overlapping; (B) age #50 years; and (C) age >50 years.
CAC ¼ coronary artery calcium; CHD ¼ coronary heart disease.
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12892.35, 95% CI: 1.58 to 3.49; p < 0.001, respectively).
Adjusted incidence of CHD shows a consistent asso-
ciation between CAC strata and CHD risk across age
subgroups (p < 0.001, each) (Figure 1). Further age-
stratiﬁed analyses were limited by low numbers of
events in each age group but suggest increasing CHD
risk in each CAC strata >10 (Table 2) and a similar
trend toward improvement in C-statistics and NRI
among younger and older individuals. The change in
C-statistics resulting from the addition of CAC to the
baseline model was 0.04 with a p value of 0.112 for
individuals #50 years and 0.05 with a p value of 0.056
among individuals >50 years. NRI in the younger
group was 0.136 with a p value of 0.347 and 0.104
with a p value of 0.353 in the older group (Table 3).
No signiﬁcant interaction between age category and
CAC on the risk of CHD was detected (p interaction ¼
0.363). There was also no signiﬁcant interaction be-
tween sex and CAC (p interaction ¼ 0.923) or race and
CAC (p interaction ¼ 0.530).
CORONARY ARTERY CALCIUM AND NET RECLASSIFICA-
TION IMPROVEMENT—REVIEW AND META-ANALYSIS.
Our initial search resulted in 47 potentially relevant
studies. After title and abstract review, 17 studieswere selected for full-text review and 3 met the pre-
determined inclusion criteria (Online Figure 4) (5–7).
Mean ages ranged from 59.4 to 69.6 years (weighed
mean 62.0  8.7 years). All studies reported signiﬁ-
cant NRI when CAC was added to a model composed
of traditional CHD risk factors (Online Table 1). The
pooled estimate for the NRI was 0.200 (95% CI: 0.140
to 0.261) and there was no evidence of heterogeneity
between studies (I2 ¼ 24%) (Figure 2A). Adding our
study to the meta-analysis results in a summary NRI
of 0.202 (95% CI: 0.146 to 0.258) and no signiﬁcant
heterogeneity (I2 ¼ 0%) (Figure 2B). The difference
between the DHS NRI and the pooled estimate from
previous studies was not signiﬁcant when tested by
the z-score (p ¼ 0.431).
DISCUSSION
In a young, multiethnic cohort, the addition of CAC to
a model composed of traditional CHD risk factors
signiﬁcantly improved discrimination and risk clas-
siﬁcation. Our ﬁndings suggest that CAC can reﬁne
CHD risk prediction in populations younger than
those previously studied and at the lower end of the
age group targeted by recent guidelines (4).
TABLE 2 Adjusted HR for Incident CHD Stratiﬁed by CAC Scores and Age Group
HR 95% CI p Value
Overall population
0 < CAC #10 1.01 0.38–2.67 0.983
10 < CAC #100 3.43 1.38–8.56 0.008
CAC >100 5.64 2.28–13.97 <0.001
Individuals #50 yrs of age
0 < CAC #10 1.28 0.38–4.32 0.689
10 < CAC #100 3.12 0.86–11.35 0.085
CAC >100 6.54 1.79–23.91 0.005
Individuals >50 yrs of age
0 < CAC #10 0.59 0.12–3.01 0.527
10 < CAC #100 2.51 0.68–9.28 0.168
CAC >100 4.09 1.14–14.68 0.031
Hazard ratios derived from separate Cox models constructed for each age group.
CAC ¼ coronary artery calcium; CHD ¼ coronary heart disease; CI ¼ conﬁdence interval; HR ¼ hazard ratio.
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1290Although there is abundant evidence in support of
CAC as a CHD risk marker, several factors may impact
its performance among younger individuals. There is
a strong direct association between CAC and age such
that CAC can be detected in <16% of 45-year-old in-
dividuals (18). Even among young individuals with
CAC >0, the overall scores tend to be low and their
impact on short-term risk classiﬁcation has not been
clearly established (19). The low prevalence of CAC in
young populations suggests that a large number of
individuals would need to be scanned to detect only a
few with high CAC scores, which could limit the
ability of CAC to discriminate and reclassify risk in
this population. Furthermore, young individuals have
a higher proportion of noncalciﬁed plaque such that
CAC may not accurately reﬂect the overall burden of
coronary atherosclerosis (20). Conversely, the early
identiﬁcation of CHD risk allows early initiation
of treatment, which may result in a higher number of
life-years saved. Our ﬁndings suggest that despite
potential limitations, CAC improves risk prediction in
younger populations.
Few previous studies have assessed the association
between CAC and adverse outcomes in young in-
dividuals (21–24). In a cohort of active military
personnel, composed of 1,634 men (mean age 42
years), Taylor et al. (21) assessed the association be-
tween CAC and CHD events. Over a mean follow-up of
5.6 years, 22 CHD events occurred, and the indepen-
dent association between CAC and CHD was only
demonstrated in the highest Framingham Risk Score
tertile. Tota-Maharaj et al. (22) followed asymptom-
atic patients referred for CAC scanning for a mean of
5.6 years. They reported that CAC was associated with
all-cause mortality across age groups including
among those <45 years of age. Similarly, LaMonteet al. (23) found that, after adjustment for sex, CAC
was associated with CHD in the subgroup of in-
dividuals under the age of 40 years. Similar to these
other studies inclusive of young adults, the effect of
CAC on discrimination and reclassiﬁcation metrics
was not assessed. More recently, a study from the
MESA (Multi-Ethnic Study of Atherosclerosis) (24)
reported that CAC was similarly associated with
CHD among individuals ages 45 through 54 years
and 75 through 84 years. Metrics of discrimination
and reclassiﬁcation were not reported. Although
these studies suggest that CAC is independently
associated with CHD and all-cause mortality in young
individuals, ours is the ﬁrst study to fully assess the
impact of CAC on clinically relevant metrics of
discrimination and reclassiﬁcation in an unselected
population.
Although we show that CAC improves risk predic-
tion in a population younger than has been studied
previously, the minimal age at which CAC becomes
informative has yet to be determined. Unfortunately
we did not have sufﬁcient numbers of CHD events to
perform further age-stratiﬁed analysis. Given the
overall low event rates among young individuals, this
type of analysis will require data pooling from mul-
tiple different cohorts.
In this study, CAC scores >0 and #10 were not
associated with higher CHD risk compared with
CAC ¼ 0 in multivariable analysis. As very few CHD
events occurred in this group (n ¼ 10), this analysis is
underpowered and should be interpreted in the
context of previous studies where even low CAC
scores were associated with higher CHD event
rates (25). The unadjusted HR of 1.75 (95% CI: 0.67 to
4.52; p ¼ 0.252) for CAC >0 and #10 and the
increasing risk with increasing CAC burden in higher
CAC categories support a graded association between
CAC and CHD risk in younger individuals.
In line with recent guidelines, participants with
diabetes were considered to be at high CHD risk and
were therefore not included in our primary analysis.
Although the use of CAC among individuals with
diabetes has been advocated by some investigators
(26), participants with diabetes were excluded from
the largest study on CAC and net reclassiﬁcation (7).
When diabetic individuals were added to our cohort,
CAC still produced a signiﬁcant NRI (0.135; p ¼ 0.043).
The NRI reported in this study is consistent
with previous reports inclusive of older participants,
and a meta-analysis of all studies including the
current study does not demonstrate signiﬁcant
heterogeneity. As seen in some of the previous studies,
the improvement in NRI was in large part driven
by correct upward risk classiﬁcation, with minimal
TABLE 3 Cross-Tabulation of Predicted Risk With and Without CAC Among Individuals With and Without Events
Events Nonevents
Baseline Model þ CAC
Total
Baseline Model þ CAC
Total<6% 6%–20% $20% <6% 6%–20% $20%
Overall Population
Baseline model
<6% 12 9 1 22 1,750 52 1 1,803
6%–20% 4 14 8 26 81 86 26 193
$20% 0 2 7 9 1 8 22 31
Total 16 25 16 57 1,832 146 49 2,027
Net effects of CAC
Increased risk 18 79
Decreased risk 6 90
Net correctly reclassiﬁed 21.1% (p ¼ 0.014) 0.5% (0.397)
NRI 0.216 (p ¼ 0.012)
Individuals #50 yrs of Age
Baseline model
<6% 6 6 0 12 1,393 25 1 1,419
6%–20% 2 4 1 7 38 23 8 69
$20% 0 2 2 4 0 4 5 9
Total 8 12 3 23 1,431 52 14 1,497
Net effects of CAC
Increased risk 7 34
Decreased risk 4 42
Net correctly reclassiﬁed 13.0% (p ¼ 0.366) 0.5% (0.359)
NRI 0.136 (p ¼ 0.347)
Individuals >50 yrs of Age
Baseline model
<6% 6 0 1 7 325 30 1 356
6%–20% 3 8 7 18 63 67 20 150
$20% 0 3 6 9 1 11 12 24
Total 9 11 14 34 389 108 33 530
Net effects of CAC
Increased risk 8 51
Decreased risk 6 75
Net correctly reclassiﬁed 5.9% (p ¼ 0.593) 4.5% (0.033)
NRI 0.104 (p ¼ 0.353)
Baseline model included age, race, sex, systolic blood pressure, total and high-density lipoprotein cholesterol, smoking status, blood pressure medication, and statin use. Events were deﬁned as coronary
heart disease death, MI, or surgical or percutaneous coronary intervention.
NRI ¼ net reclassiﬁcation improvement; other abbreviations as in Table 1.
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1291impact on downward risk classiﬁcation (7). This
ﬁnding supports recent guideline recommendations
that primarily endorse the use of CAC scanning as a tool
to upreclassify cardiovascular risk (10).
Our study extends the previous observation that
CAC improves CHD risk prediction to a population
with a mean age of 44 years. This suggests that CAC
scanning may have clinical utility in individuals at
the lower end of the age range targeted by the most
recent guidelines.
STUDY LIMITATIONS. Even with a mean follow-up
period of over 9 years, few hard CHD events
occurred in this relatively young cohort. The primaryoutcome chosen for this analysis therefore also
included coronary revascularization events, but only
those occurring after a blanking period of 3 months
from the CAC measurement. The same pattern of
results, however, was seen when only hard CHD
events were included, and our primary outcome was
similar to that used in other studies assessing CAC
and NRI (2,7,27). Age-stratiﬁed analyses showed
an independent association between CAC and CHD,
but both the change in C-statistics and NRI were not
statistically signiﬁcant. However, the similar magni-
tude of both parameters in the younger and older
groups and the absence of signiﬁcant interaction
FIGURE 2 Meta-Analysis of CAC Studies Reporting NRI for CHD Events
Studies Estimate (95% CI)
MESA 2010 0.250 (0.162 - 0.338)
HNR 2010 0.196 (0.063 - 0.329)
Rotterdam 2010 0.140 (0.040 - 0.240)
Overall (I2 = 24%; p = 0.270) 0.200 (0.140, 0.261)
A
-1 -0.5 0 0.5 1
Studies Estimate (95% CI)
MESA 2010 0.250 (0.162 - 0.338)
HNR 2010 0.196 (0.063 - 0.329)
Rotterdam 2010 0.140 (0.040 - 0.240)
DHS 2014 0.213 (0.044 - 0.382)
Overall (I2 = 0%; p = 0.451) 0.202 (0.146, 0.258)
B
-1 -0.5 0 0.5 1
CI ¼ conﬁdence interval; DHS ¼ Dallas Heart Study; HNR ¼ Heinz Nixdorf Recall Study; MESA ¼ Multi-Ethnic Study of Atherosclerosis;
NRI ¼ net reclassiﬁcation improvement; other abbreviations as in Figure 1.
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1292between age and CAC suggest that there is no het-
erogeneity in the relationship between CAC and
CHD among individuals under or over 50 years of age
and that the lack of statistical signiﬁcance may be a
result of limited power. The ﬁnal analysis excluded
226 participants with uninterpretable CAC scans.
Obesity was more prevalent among those with unin-
terpretable scans (body mass index: 43 kg/m2 vs.
29 kg/m2; p < 0.001), which may limit the generaliza-
tion of our ﬁndings to those with very high body mass
index. NRI is a central metric in this study and
has several limitations, one of them being the
similar importance given to reclassiﬁcation to inter-
mediate- and high-risk categories. To make our ﬁnd-
ings comparable to other studies inclusive of older
participants, our outcome was incident CHD and
not atherosclerotic cardiovascular disease as recom-
mended by the most recent guidelines (4). Further
studies are needed to assess the performance of CAC
using this more inclusive endpoint. As in previous
studies, CAC was modeled as a continuous variable, a
strategy that may not be immediately applicable in
clinical practice. Studies are underway to create a
regression-based calculator that integrates CAC and
traditional risk factors.The studies included in the meta-analysis have
minor methodological differences such as slightly
different composite CHD outcomes. One study also
employed different risk categories (i.e., <10%, 10% to
20%, and >20% 10-year risk) (5). Although this may
limit the precision of the NRI pooled estimates, sig-
niﬁcant net correct reclassiﬁcation was reported by
all studies and no signiﬁcant heterogeneity was
observed in the meta-analysis. Because only 4 studies
were included in the meta-analysis, the I2 test may be
underpowered.
CONCLUSIONS
In a population substantially younger than those
previously studied (mean age: 44.4  9.0 years), the
addition of CAC to a traditional risk factor model
improved risk discrimination and net correct reclas-
siﬁcation. Further studies are needed to determine
the optimal age to consider CAC scanning.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: CAC
scores improve CHD risk prediction in younger individuals
(i.e., mean age: 44 years).
COMPETENCY IN PATIENT CARE AND PROCEDURAL
SKILLS: CAC scanning can be considered in younger
individuals when the decision to institute preventive
measures is uncertain.
TRANSLATIONAL OUTLOOK: Further studies with
pooled data from multiple cohorts are needed to deter-
mine the optimal age to consider CAC scanning.
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